Nexstem

Market position

Positions itself as foundational infrastructure for brain- and body-signal applications rather than an end-user application vendor, with practitioners citing deployability and usability outside controlled lab environments as its distinguishing focus.

The company emphasizes research-grade signal quality in a miniaturized, portable form factor, plug-and-play integration across hardware and software so customers can skip in-house R&D, and a proprietary multimodal biosignal dataset intended to compound over time.

Technology

The platform captures high-fidelity, programmable and portable biosignals including EEG, ECG and EMG, and pairs acquisition hardware with integrated software and data tooling. The flagship hardware is Instinct, a 13-channel wireless EEG headset. The company states its approach is grounded in applied neuroscience and validated through studies and pilots, and that it is assembling a growing multimodal biosignal dataset to strengthen its models.

Go-to-market

Direct sales and enterprise co-creation engagements, supported by a developer- and researcher-oriented product waitlist, downloadable whitepaper and comparative study, and third-party endorsements from clinicians and neurotech practitioners.

Researchers, developers and neurotech companies, plus enterprises across research and cognitive science, healthcare and neurorehabilitation, consumer wearables and wellness, education and learning, defense and aerospace, and gaming and immersive media.

History

The company operated as Nexstem before announcing on January 13, 2026 that it had renamed itself Anthriq, describing the change as reflecting a broader focus on human-aware technology. In December 2025 it announced Project Kinesis, a research project on human-machine interaction.